{"version":"1.0","type":"link","title":"A phase 1 trial of romidepsin, azacitidine, dexamethasone and lenalidomide in relapsed or refractory T-cell lymphoma.","author_name":"Gordon MJ 외","author_url":"https://prs-insight.online/author/Gordon%20MJ","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/161817","thumbnail_width":1200,"thumbnail_height":630}